Chromadex Stock Price. Everything You Need To Know About The Chromadex Stock!
Chromadex Corp. is a global bioscience company headquartered in Los Angeles, California that focuses on acquiring, developing, and commercializing proprietary-based ingredient technologies. With 113 full-time employees and an IPO date of 2007-06-25, Chromadex has three distinct segments – Consumer Products, Ingredients, and Analytical Reference Standards and Services.
The Consumer Products segment provides finished dietary supplement products that contain Chromadex’s proprietary-based ingredients directly to consumers, as well as to distributors. The Ingredients segment is responsible for developing and commercializing ingredient technologies, supplying these ingredients as raw materials to manufacturers of consumer products. Specifically, the company provides Niagen in ingredient form to its strategic partners. In addition to Niagen, the company also offers Immulina, a spirulina extract.
The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services. Chromadex is committed to delivering high-quality products to its customers, ensuring the efficacy and safety of its ingredients through rigorous testing and analysis.
Investors interested in stocks share price today, including Chromadex Corp., should research the company’s latest developments and strategies to make informed investment decisions. It is essential to keep an eye on premarket trends to stay up-to-date with the latest industry news. Remember that investing involves risks, and past performance is not a guarantee of future results. As with any investment opportunity, it is crucial to do your own research and speak with a financial advisor before making any decisions.
Chromadex Stock Price. Everything You Need To Know About The Chromadex Stock! performance
- Employees 113
- Company HQ Los Angeles
- Website https://chromadex.com/default.aspx
- CDXC Asset Type Common Stock
- CDXC Market Capitalization 268.1M
- Earnings Per Share -0.07
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Chromadex, a leading company in the health and wellness sector. Chromadex specializes in discovering, developing, and commercializing patented scientific products that promote longevity, performance, and general well-being. With their innovative portfolio, Chromadex has attracted attention from investors worldwide. But how can you invest in Chromadex from Malaysia, Thailand, Indonesia, or Vietnam? The first step is to open an account with Zorion, a trusted investment platform that allows users to invest in real US stocks and Pre-IPO companies. Once you have successfully created an account, Zorion offers investment insights and recommendations to help you make informed decisions. With their expert analysis, you can maximize your investment potential. Furthermore, Zorion understands the importance of education in investing. Retail investors from Malaysia, Thailand, Indonesia, and Vietnam can access a wide range of resources and educational materials to enhance their investment knowledge. Whether you are a beginner or an experienced investor, Zorion provides valuable information to make your investment journey successful. So, start investing in Chromadex today and take advantage of the expertise and resources provided by Zorion. Don’t miss out on the opportunity to grow your portfolio and secure your financial future. Sign up now and make informed investment decisions with Zorion and Chromadex.
